The Physiological Role of Cytotoxic CD4(+) T-cells: the Holy Grail?

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 2004 Sep 18

PMID 15373899

Citations 53

Authors

V Appay

Affiliations

Soon will be listed here.

Citing Articles

Bediaga N, Garnham A, Naselli G, Bandala-Sanchez E, Stone N, Cobb J Diabetes. 2022; 71(3):566-577.

PMID: 35007320 PMC: 8893947. DOI: 10.2337/db21-0612.

Human CD4+ T-Cell Clone Expansion Leads to the Expression of the Cysteine Peptidase Inhibitor Cystatin F.

Perisic Nanut M, Pawelec G, Kos J Int J Mol Sci. 2021; 22(16).

PMID: 34445118 PMC: 8395124. DOI: 10.3390/ijms22168408.

Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer.

Cachot A, Bilous M, Liu Y, Li X, Saillard M, Cenerenti M Sci Adv. 2021; 7(9).

PMID: 33637530 PMC: 7909889. DOI: 10.1126/sciadv.abe3348.

Immune Response to SARS-CoV-2 Infection in Obesity and T2D: Literature Review.

Perez-Galarza J, Procel C, Canadas C, Aguirre D, Pibaque R, Bedon R Vaccines (Basel). 2021; 9(2).

PMID: 33572702 PMC: 7911386. DOI: 10.3390/vaccines9020102.

Systematic Examination of Antigen-Specific Recall T Cell Responses to SARS-CoV-2 versus Influenza Virus Reveals a Distinct Inflammatory Profile.

Law J, Koh W, Budylowski P, Lin J, Yue F, Abe K J Immunol. 2020; 206(1):37-50.

PMID: 33208459 PMC: 7750861. DOI: 10.4049/jimmunol.2001067.

References

Amyes E, Hatton C, Montamat-Sicotte D, Gudgeon N, Rickinson A, McMichael A . Characterization of the CD4+ T cell response to Epstein-Barr virus during primary and persistent infection. J Exp Med. 2003; 198(6):903-11. PMC: 2194204. DOI: 10.1084/jem.20022058. View

Day C, Seth N, Lucas M, Appel H, Gauthier L, Lauer G . Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers. J Clin Invest. 2003; 112(6):831-42. PMC: 193667. DOI: 10.1172/JCI18509. View

Harari A, Petitpierre S, Vallelian F, Pantaleo G . Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy. Blood. 2003; 103(3):966-72. DOI: 10.1182/blood-2003-04-1203. View

Yue F, Kovacs C, Dimayuga R, Parks P, Ostrowski M . HIV-1-specific memory CD4+ T cells are phenotypically less mature than cytomegalovirus-specific memory CD4+ T cells. J Immunol. 2004; 172(4):2476-86. DOI: 10.4049/jimmunol.172.4.2476. View

Zaunders J, Dyer W, Wang B, Munier M, Miranda-Saksena M, Newton R . Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infection. Blood. 2003; 103(6):2238-47. DOI: 10.1182/blood-2003-08-2765. View

Papagno L, Spina C, Marchant A, Salio M, Rufer N, Little S . Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection. PLoS Biol. 2004; 2(2):E20. PMC: 340937. DOI: 10.1371/journal.pbio.0020020. View

Wolint P, Betts M, Koup R, Oxenius A . Immediate cytotoxicity but not degranulation distinguishes effector and memory subsets of CD8+ T cells. J Exp Med. 2004; 199(7):925-36. PMC: 2211884. DOI: 10.1084/jem.20031799. View

Porakishvili N, Kardava L, Jewell A, Yong K, Glennie M, Akbar A . Cytotoxic CD4+ T cells in patients with B cell chronic lymphocytic leukemia kill via a perforin-mediated pathway. Haematologica. 2004; 89(4):435-43. View

Purbhoo M, Irvine D, Huppa J, Davis M . T cell killing does not require the formation of a stable mature immunological synapse. Nat Immunol. 2004; 5(5):524-30. DOI: 10.1038/ni1058. View

10.

Gamadia L, van Leeuwen E, Remmerswaal E, Yong S, Surachno S, Wertheim-van Dillen P . The size and phenotype of virus-specific T cell populations is determined by repetitive antigenic stimulation and environmental cytokines. J Immunol. 2004; 172(10):6107-14. DOI: 10.4049/jimmunol.172.10.6107. View

11.

Appay V, Rowland-Jones S . Lessons from the study of T-cell differentiation in persistent human virus infection. Semin Immunol. 2004; 16(3):205-12. DOI: 10.1016/j.smim.2004.02.007. View

12.

Gamadia L, Rentenaar R, van Lier R, Ten Berge I . Properties of CD4(+) T cells in human cytomegalovirus infection. Hum Immunol. 2004; 65(5):486-92. DOI: 10.1016/j.humimm.2004.02.020. View

13.

Lucas M, Day C, Wyer J, Cunliffe S, Loughry A, McMichael A . Ex vivo phenotype and frequency of influenza virus-specific CD4 memory T cells. J Virol. 2004; 78(13):7284-7. PMC: 421690. DOI: 10.1128/JVI.78.13.7284-7287.2004. View

14.

Lyadova I, Oberdorf S, Kapina M, Apt A, Swain S, Sayles P . CD4 T cells producing IFN-gamma in the lungs of mice challenged with mycobacteria express a CD27-negative phenotype. Clin Exp Immunol. 2004; 138(1):21-9. PMC: 1809176. DOI: 10.1111/j.1365-2249.2004.02573.x. View

15.

Krensky A, Reiss C, Mier J, Strominger J, Burakoff S . Long-term human cytolytic T-cell lines allospecific for HLA-DR6 antigen are OKT4+. Proc Natl Acad Sci U S A. 1982; 79(7):2365-9. PMC: 346194. DOI: 10.1073/pnas.79.7.2365. View

16.

Fleischer B . Acquisition of specific cytotoxic activity by human T4+ T lymphocytes in culture. Nature. 1984; 308(5957):365-7. DOI: 10.1038/308365a0. View

17.

Lukacher A, Morrison L, Braciale V, Malissen B, Braciale T . Expression of specific cytolytic activity by H-2I region-restricted, influenza virus-specific T lymphocyte clones. J Exp Med. 1985; 162(1):171-87. PMC: 2187708. DOI: 10.1084/jem.162.1.171. View

18.

McCarthy S, Singer A . Recognition of MHC class I allodeterminants regulates the generation of MHC class II-specific CTL. J Immunol. 1986; 137(10):3087-92. View

19.

Man S, Lechler R, Batchelor J, Sharrock C . Individual variation in the frequency of HLA class II-specific cytotoxic T lymphocyte precursors. Eur J Immunol. 1990; 20(4):847-54. DOI: 10.1002/eji.1830200420. View

20.

Littaua R, Oldstone M, Takeda A, Ennis F . A CD4+ cytotoxic T-lymphocyte clone to a conserved epitope on human immunodeficiency virus type 1 p24: cytotoxic activity and secretion of interleukin-2 and interleukin-6. J Virol. 1992; 66(1):608-11. PMC: 238325. DOI: 10.1128/JVI.66.1.608-611.1992. View